AI-powered Precision Analytics Solution for Ultra-Low-Dose CT Lung Cancer Screening
ClariPulmo
With the unique built-in features including powerful denoising and kernel normalization, ClariPulmo provides accurate and consistent detection and measurement results despite the heterogeneous scan and reconstruction conditions which are frequently encountered in real world environments.
Lung Cancer Facts
Lung cancer accounts for nearly 160,000 deaths per year in the U.S., and there are more than 224,000 new lung cancer cases every year in the U.S1.
An estimated 154,050 Americans are expected to die from lung cancer in 2018,
×
Join Us at RSNA 2024 and Experience the Difference!
Dec 1, 2024 - Dec 4, 2024
McCormick Place, Chicago
ClariPi will be at RSNA this year! If you are interested in our products, you could visit our booth or arrange a demo session online. Just message us to schedule a meeting! Thank you!
Title: An Experience at Mass General Brigham – AI-Aided Contrast Augmentation of Suboptimal Chest CT and CTPA and Abdominal-Pelvis CT Examinations: ClariPi Inc
Tuesday, Dec 3 2:00 PM – 2:20 PM CST
Speaker: Lina Karout, MD
Dr. Karout, is a postdoctoral research fellow at Massachusetts General Hospital and Harvard Medical School. She has been working at the Webster Center for Quality and Safety and MGB AI over the last two years on multiple projects related to artificial intelligence applications in medical imaging and radiation dose optimization.